Many tumor types, such as RCC, and those tumors associated with von-Hippel Lindau (VHL) syndrome create “pseudohypoxia” via inactivating mutations of the VHL protein that would normally ubiquitinate HIF-1α. The gene discussed is HIF1A; the disease is neoplasm.